Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Celanese Eva Performance Polymers LLC manages 7 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 6 distinct examiners and 5 distinct art units. This distribution suggests a broad prosecution front across multiple specialized groups, indicating a diverse range of pharmaceutical or biotechnological innovations. The presence of 7 pending office actions shows the current scale of the company's active portfolio.
BARBER, KIMBERLY is the busiest examiner for this portfolio. She is currently responsible for 2 pending office actions. With 6 distinct examiners and 5 distinct art units involved, the company must navigate a variety of examination styles and technical requirements. This complexity requires a coordinated effort to ensure consistency across the different examiners who are reviewing the company's filings. BARBER, KIMBERLY handles the largest individual share with the 2 pending office actions assigned to her.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Double-patenting + other | 2 (40%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARBER, KIMBERLY | 2 | 72.6% | +19.7% |
| BASQUILL, SEAN M | 1 | 38.8% | +21.7% |
| PRAGANI, RAJAN | 1 | 52.4% | +71.4% |
| ZAMORY, JUSTIN L | 1 | 72.7% | +17.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18171406 | Intravaginal Ring Device for the Delivery of Aromatase Inhibitor | BASQUILL, SEAN M | 17d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18157134 | Method for Prohibiting and/or Treating an Eye Condition | BARBER, KIMBERLY | 26d overdue |
| 18171406 | Intravaginal Ring Device for the Delivery of Aromatase Inhibitor | BASQUILL, SEAN M | 17d overdue |
| 18474292 | Implantable Medical Device for the Delivery of a Nucleic Acid | BARBER, KIMBERLY | — |
| 18157123 | Implantable Device for Delivery of a Tyrosine Kinase Inhibitor | PRAGANI, RAJAN | — |
| 17948271 | Refillable Implantable Device for Delivering a Drug Compound | ZAMORY, JUSTIN L | — |
| Art Unit | Apps |
|---|---|
| 1614 | 2 |
| 1637 | 1 |
| 1615 | 1 |
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18474292 | Implantable Medical Device for the Delivery of a Nucleic Acid | BARBER, KIMBERLY | 1637 | §103§112DP | Non-Final OA | — | Pending | Sep 26, 2023 |
| 18171406 | Intravaginal Ring Device for the Delivery of Aromatase Inhibitor | BASQUILL, SEAN M | 1614 | §103§112 | Final Rejection | 17d overdue | Pending | Feb 20, 2023 |
| 18157134 | Method for Prohibiting and/or Treating an Eye Condition | BARBER, KIMBERLY | 1615 | §103 | Final Rejection | 26d overdue | Pending | Jan 20, 2023 |
| 18157123 | Implantable Device for Delivery of a Tyrosine Kinase Inhibitor | PRAGANI, RAJAN | 1614 | §103§112DP | Final Rejection | — | Pending | Jan 20, 2023 |
| 17948271 | Refillable Implantable Device for Delivering a Drug Compound | ZAMORY, JUSTIN L | 3783 | §103Other | Final Rejection | — | Pending | Sep 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCelanese Eva Performance Polymers LLC has 5 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Kimberly Barber has the most, with 2 of Celanese Eva Performance Polymers LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
